Omar Pacha, M.D.
Department of Dermatology, Division of Internal Medicine
Present Title & Affiliation
Primary Appointment
Assistant Professor, Department of Dermatology, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
Education & Training
Degree-Granting Education
| 2010 | Baylor College of Medicine, Houston, TX, USA, MD, Doctor of Medicine |
| 2005 | Texas A&M University, College Station, TX, USA, BS, Biomedical Science |
Postgraduate Training
| 2012-2015 | Clinical Residency, Department of Dermatology, University of Texas Medical School, Houston, TX |
| 2011-2012 | Research Fellowship, Department of Dermatology, University of Texas Medical School, Houston, TX |
| 2010-2011 | Surgical Internship, Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, TX |
Selected Publications
Peer-Reviewed Articles
- Messer A, Brown AE, Pacha O, Boddu P, Geppner A, Kadia TM, Huen AO. Successful treatment of cutaneous adult T-cell leukemia/lymphoma with imiquimod. JAAD Case Rep 5(11):979-981, 2019. e-Pub 2019. PMID: 31709290.
- Nisha A Reddy, Steven R Mays, Omar Pacha. Kaposi's sarcoma in the immunosuppressed. Journal of Immunotherapy and Precision Oncology, 2019. e-Pub 2019.
- Tetzlaff MT, Nagarajan P, Chon S, Huen A, Diab A, Omar P, Aung PP, Torres-Cabala CA, Mays SR, Prieto VG, Curry JL. Lichenoid Dermatologic Toxicity From Immune Checkpoint Blockade Therapy: A Detailed Examination of the Clinicopathologic Features. Am J Dermatopathol 39(2):121-129, 2017. PMID: 28134729.
- J. Curry; M. Tetzlaff; C. Torres-Cabala; O. Pacha; A. Huen; P. Nagarajan; A. Diab; C. Drucker; R. Rapini; V. Prieto. Clinical and histologic patterns of dermatologic toxicity from immune checkpoint blockade therapy. Experimental Dermatology, 2016.
- Pacha O, Schlichte MJ, Hebert AA. Psoriasis and Pityriasis Rubra Pilaris. in: Severe Skin Diseases in Children:21-35, 2014. e-Pub 2014.
- Pacha O, Hebert AA. Ecthyma gangrenosum and neutropenia in a previously healthy child. Pediatr Dermatol 30(6):e283-4, 2013. e-Pub 2012. PMID: 22471737.
- Pacha O, Hebert AA. Pediatric photosensitivity disorders. Dermatol Clin 31(2):317-26, 2013. PMID: 23557658.
- Gifford KA, Pacha O, Hebert AA, Nelson CL, Kirsner SM, Ballo MT, Bloom ES. A new paradigm for calculating skin dose. Brachytherapy 12(2):114-9, 2013. e-Pub 2012. PMID: 22884255.
- Pacha O, Kadikoy H, Amro M, Haque W, Abdellatif A. Torsades de pointes and prolonged QT syndrome in Takotsubo cardiomyopathy. J Cardiovasc Med (Hagerstown) 13(8):536-40, 2012. PMID: 20075742.
- Gupta A, Pacha O, Skaria R, Huynh T, Truong L, Abdellatif A. Retroperitoneal sarcoma presenting as acute renal failure, secondary to bilateral renal artery invasion. Clin Nephrol 78(2):164-8, 2012. PMID: 22790462.
- Phillips CB, Pacha O, Biliciler-Denkta G, Hebert AA. A review of beta antagonist treatment for infantile hemangioma. J Drugs Dermatol 11(7):826-9, 2012. PMID: 22777223.
- Pacha O, Pickett MM, Hebert AA. Scrotal Buschke-Lowenstein tumor in an AIDS patient. Sex Transm Dis 39(3):236-7, 2012. PMID: 22337113.
- Pacha O, Hebert AA. Treating atopic dermatitis: safety, efficacy, and patient acceptability of a ceramide hyaluronic acid emollient foam. Clin Cosmet Investig Dermatol 5:39-42, 2012. e-Pub 2012. PMID: 22690129.
- Pacha O, Sambrano BL, Hebert AA. Skin Barrier Repair in Eczema: A Review of Current Understanding of Pathophysiology and Treatment 3(1):115-122, 2012. e-Pub 2012.
- Haque W, Kadikoy H, Pacha O, Maliakkal J, Hoang V, Abdellatif A. Osteonecrosis secondary to antiphospholipid syndrome: a case report, review of the literature, and treatment strategy. Rheumatol Int 30(6):719-23, 2010. e-Pub 2009. PMID: 20012628.
- Fanari Z, Kadikoy H, Haque W, Pacha O, Abdellatif A. Medical management of primary hyperparathyroidism with concomitant multiple myeloma. Intern Med 49(6):581-4, 2010. e-Pub 2010. PMID: 20228595.
- Pacha O, Cohn WE, Dinh T, Fishman IJ. Fluroscopy guided implantation of penile prosthesis in cases of severe fibrosis. Mens Health 7(1):42-44, 2010. e-Pub 2010.
- Pacha O, Sallman MA, Evans SE. COVID-19: a case for inhibiting IL-17?. Nat Rev Immunol. e-Pub 2020. PMID: 32358580.
- Chen WS, Tetzlaff MT, Diwan H, Jahan-Tigh R, Diab A, Nelson K, Glitza IC, Kaunitz GJ, Johnson D, Torres-Cabala C, Pacha O, Taube JM, Maloney K, Prieto VG, Curry JL. Suprabasal acantholytic dermatologic toxicities associated checkpoint inhibitor therapy: A spectrum of immune reactions from paraneoplastic pemphigus-like to Grover-like lesions. J Cutan Pathol. e-Pub 2018. PMID: 29943453.
Other Articles
- Saisindhu Narala, MD; Natalie Kash, MD; Omar Pacha, MD An unusual presentation of blastic plasmacytoid dendritic cell neoplasm. Journal of the American Academy of Dermatology, 2019.
Abstracts
- Woo Cheal Cho, MD1, Ramya Vangipuram, MD2; Omar Pacha, MD2; Priyadharsini Nagarajan, MD, PhD.1. Cutaneous Metastasis of Medullary Thyroid Carcinoma with Interstitial Growth Pattern. College of American Pathologists.
- Pacha O, Pacha R, Hebert A. Rickettsia on Safari.
- Gupta A, Pacha O, Huynh T, Abdellatif A.. Retroperitoneal Sarcoma Presenting as Acute Renal Failure Secondary to Bilateral Renal Artery Invasion/Stenosis.
- Perito P, Pacha O, Khera M. Intra-Facial Placement of the penile prosthesis reservoir: A Novel Technique for the High Risk Patient.
- Pacha O, Hebert A.A.. Beta Blocker Use in Infantile Hemangiomas: A three year summary of clinical experience.
Book Chapters
- Patel AB, Pacha O. Skin Reactions to Immune Checkpoint Inhibitors. In: Adv Exp Med Biol, 235-246, 2020.
- Patel AB, Pacha O. Skin Reactions to Immune Checkpoint Inhibitors. In: Adv Exp Med Biol, 117-129, 2018.
- Patel AB, Pacha O. Skin Reactions to Immune Checkpoint Inhibitors. In: Adv Exp Med Biol. Springer, 175-184, 2017.
- Pacha O, Schlichte M, Hebert A.A.. Severe Skin Diseases in Children: Beyond Topical Therapy. In: Severe Psoriasis and Pityriasis Rubra Pilaris in Children, 2013.
- Pacha O, Hebert AA. Hemangiomas. In: Treatment of Skin Disease, 2013.
Grant & Contract Support
| Title: | MD Anderson Institutional Research Grant "Biomarker Profiling Immunotherapy Related Cutaneous Adverse Events" |
| Funding Source: | MD Anderson |
| Role: | Principal Investigator |